Tumor budding and E-Cadherin expression in endometrial carcinoma: Are they prognostic factors in endometrial cancer?

Gynecologic Oncology

Volumn 125, Issue 1, 2012, Pages 208-213

  Koyuncuoglu, Meral ^a   Okyay, Emre ^a   Saatli, Bahadir ^a   Olgan, Safak ^a   Akin, Mustafa ^b   Saygili, Ugur ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b MUSTAFA KEMAL UNIVERSITY   (Turkey)

Author keywords

Budding; E cadherin; Endometrial carcinoma; Prognosis

Indexed keywords

ANTIBODY; UVOMORULIN;

ARTICLE; CANCER CELL; CANCER GRADING; CANCER INVASION; CANCER SURVIVAL; CELL DIFFERENTIATION; CLINICAL EVALUATION; CLINICAL EXAMINATION; CLINICAL FEATURE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MEDICAL EXAMINATION; MYOMETRIUM; OVERALL SURVIVAL; PATHOLOGY; POSTOPERATIVE PERIOD; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR BUDDING;

ADULT; AGED; AGED, 80 AND OVER; CADHERINS; CARCINOMA, ENDOMETRIOID; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84858338803     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.12.433     Document Type: Article

References (36)

1. J. Prat Prognostic parameters of endometrial carcinoma Hum Pathol 35 2004 649 662 (Pubitemid 38881074)
2. J.V. Bokhman Two pathogenetic types of endometrial carcinoma Gynecol Oncol 15 1983 10 17 (Pubitemid 13194678)
3. T. Morodomi, H. Isomoto, K. Shirouzu, K. Kakegawa, K. Irie, and M. Morimatsu An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancer Cancer 63 3 1989 539 543 (Pubitemid 19038471)
4. H.J. Choi, K.J. Park, J.S. Shin, M.S. Roh, H.C. Kwon, and H.S. Lee Tumor budding as a prognostic marker in stage-III rectal carcinoma Int J Colorectal Dis 22 8 2007 863 868
5. H. Kanazawa, H. Mitomi, Y. Nishiyama, I. Kishimoto, N. Fukui, and T. Nakamura Tumour budding at invasive margins and outcome in colorectal cancer Colorectal Dis 10 1 2008 41 47 (Pubitemid 350238562)
6. M.S. Roh, J.I. Lee, and P.J. Choi Tumor budding as a useful prognostic marker in esophageal squamous cell carcinoma Dis Esophagus 17 4 2004 333 337 (Pubitemid 40123811)
7. S. Sarioglu, C. Acara, F.C. Akman, N. Dag, C. Ecevit, and A.O. Ikiz Tumor budding as a prognostic marker in laryngeal carcinoma Pathol Res Pract 206 2 2010 88 92
8. T. Okuyama, M. Oya, and H. Ishikawa Budding as a risk factor for lymph node metastasis in pT1 or pT2 well-differentiated colorectal adenocarcinoma Dis Colon Rectum 45 5 2002 628 634 (Pubitemid 34507238)
9. K. Hase, C. Shatney, D. Johnson, M. Trollope, and M. Vierra Prognostic value of tumor "budding" in patients with colorectal cancer Dis Colon Rectum 36 7 1993 627 635 (Pubitemid 23206317)
10. T. Masaki, A. Goto, M. Sugiyama, H. Matsuoka, N. Abe, and A. Sakamoto Possible contribution of CD44 variant 6 and nuclear beta-catenin expression to the formation of budding tumor cells in patients with T1 colorectal carcinoma Cancer 92 10 2001 2539 2546 (Pubitemid 33049436)
11. A.N. Scholten, R. Aliredjo, C.L. Creutzberg, and V.T. Smit Combined E-cadherin, alpha-catenin, and beta-catenin expression is a favorable prognostic factor in endometrial carcinoma Int J Gynecol Cancer 16 3 2006 1379 1385 (Pubitemid 43886773)
12. K. Holcomb, R. Delatorre, B. Pedemonte, C. McLeod, L. Anderson, and J. Chambers E-cadherin expression in endometrioid, papillary serous, and clear cell carcinoma of the endometrium Obstet Gynecol 100 6 2002 1290 1295 (Pubitemid 35449197)
13. A. Gupta, C.G. Deshpande, and S. Badve Role of E-cadherins in development of lymphatic tumor emboli Cancer 97 9 2003 2341 2347 (Pubitemid 36444081)
14. T. Fujioka, Y. Takebayashi, T. Kihana, Y. Kusanagi, K. Hamada, and H. Ochi Expression of E-cadherin and beta-catenin in primary and peritoneal metastatic ovarian carcinoma Oncol Rep 8 2 2001 249 255 (Pubitemid 33758073)
15. R. Yoshida, N. Kimura, Y. Harada, and N. Ohuchi The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer Int J Oncol 18 3 2001 513 520
16. K.R. Lee, F.A. Tavassoli, and J. Prat Tumours of the uterine corpus F.A. Tavassoli, P. Devilee, World Health Organization classification of tumours Pathology and genetics of the breast and female genital organs. 2003 IARC Pres Lyon 217 228
17. J.L. Benedet, H. Bender, H. Jones III, H.Y. Ngan, and S. Pecorelli FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology Int J Gynaecol Obstet 70 2000 209 262
18. H. Ueno, J. Murphy, J.R. Jass, H. Mochizuki, and I.C. Talbot Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer Histopathology 40 2 2002 127 132 (Pubitemid 34122114)
19. F. Prall Tumour budding in colorectal carcinoma Histopathology 50 1 2007 151 162 (Pubitemid 44953405)
20. T. Masaki, H. Matsuoka, M. Sugiyama, N. Abe, A. Sakamoto, and Y. Atomi Actual number of tumor budding as a new tool for the individualization of treatment of T1 colorectal carcinomas J Gastroenterol Hepatol 21 7 2006 1115 1121
21. D.K. Sohn, H.J. Chang, J.W. Park, D.H. Choi, K.S. Han, and C.W. Hong Histopathological risk factors for lymph node metastasis in submucosal invasive colorectal carcinoma of pedunculated or semipedunculated type J Clin Pathol 60 8 2007 912 915 (Pubitemid 47234439)
22. Y. Moriya, T. Niki, T. Yamada, Y. Matsuno, H. Kondo, and S. Hirohashi Increased expression of laminin-5 and its prognostic significance in lung adenocarcinomas of small size. An immunohistochemical analysis of 102 cases Cancer 91 6 2001 1129 1141 (Pubitemid 32295418)
23. M. Koike, Y. Kodera, Y. Itoh, G. Nakayama, M. Fujiwara, and N. Hamajima Multivariate analysis of the pathologic features of esophageal squamous cell cancer: tumor budding is a significant independent prognostic factor Ann Surg Oncol 15 7 2008 1977 1982
24. H. Gabbert, R. Wagner, R. Moll, and C.D. Gerharz Tumor dedifferentiation: an important step in tumor invasion Clin Exp Metastasis 3 4 1985 257 279 (Pubitemid 16176417)
25. K. Guzińska-Ustymowicz MMP-9 and cathepsin B expression in tumor budding as an indicator of a more aggressive phenotype of colorectal cancer (CRC) Anticancer Res 26 2006 1589 1594
26. M.J. Gosens, L.C. van Kempen, C.J. van de Velde, J.H. van Krieken, and I.D. Nagtegaal Loss of membranous Ep-CAM in budding colorectal carcinoma cells Mod Pathol 20 2 2007 221 232 (Pubitemid 46422177)
27. R. Shaco-Levy, S. Sharabi, B. Piura, and N. Sion-Vardy MMP-2, TIMP-1, E-cadherin, and beta-catenin expression in endometrial serous carcinoma compared with low-grade endometrial endometrioid carcinoma and proliferative endometrium Acta Obstet Gynecol Scand 87 2008 868 874
28. T.Z. Yi, J. Guo, L. Zhou, X. Chen, R.R. Mi, and Q.X. Qu Prognostic value of E-cadherin expression and CDH1 promoter methylation in patients with endometrial carcinoma Cancer Invest 29 1 2011 86 92
29. N. Sakuragi, M. Nishiya, K. Ikeda, T. Ohkouch, E.E. Furth, and H. Hareyama Decreased E-cadherin expression in endometrial carcinoma is associated with tumor dedifferentiation and deep myometrial invasion Gynecol Oncol 53 2 1994 183 189 (Pubitemid 24177042)
30. C.A. Rubio Adenocarcinoma in inflammatory colorectal disease. Histological features pertinent to local tumour progression Anticancer Res 23 5b 2003 4313 4318 (Pubitemid 37474939)
31. E. Syk, C. Lenander, P.J. Nilsson, C.A. Rubio, and B. Glimelius Tumour budding correlates with local recurrence of rectal cancer Colorectal Dis 13 3 2011 255 262
32. F. Prall, H. Nizze, and M. Barten Tumour budding as prognostic factor in stage III colorectal carcinoma Histopathology 47 1 2005 17 24 (Pubitemid 40978809)
33. C.A. Rubio Arrest of cell proliferation in budding tumor cells ahead of the invading edge of colonic carcinomas. A preliminary report Anticancer Res 28 4 C 2008 2417 2420
34. S. Baranwal, and S.K. Alahari Molecular mechanisms controlling E-cadherin expression in breast cancer Biochem Biophys Res Commun 384 2009 6 11
35. G. Moreno-Bueno, D. Hardisson, D. Sarrió, C. Sánchez, R. Cassia, and J. Prat Abnormalities of E- and P-cadherin and catenin (beta-, gamma-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia J Pathol 199 4 2003 Apr 471 478 (Pubitemid 36411224)
36. T. Yalta, L. Atay, F. Atalay, M. Caydere, M. Gonultas, and H. Ustun E-cadherin expression in endometrial malignancies: comparison between endometrioid and non-endometrioid carcinomas J Int Med Res 37 1 2009 Jan-Feb 163 168